A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults
PHASE2CompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Conditions
Hypertrophic Scar
Interventions
DRUG
RXI-109
surgery.
DRUG
Placebo
surgery.
Trial Locations (5)
28078
Huntersville
33461
Lake Worth
60611
Chicago
63141
St Louis
Unknown
San Pedro Sula
All Listed Sponsors
lead
RXi Pharmaceuticals, Corp.
INDUSTRY
NCT02030275 - A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults | Biotech Hunter | Biotech Hunter